Roles of CD4+ T cells as mediators of antitumor immunity
Dmitriy Kravtsov, Amy K. Erbe, Paul M. Sondel, Alexander L. Rakhmilevich
Abstract
It has been well established that CD8+ T cells serve as effector cells of the adaptive immune response against tumors, whereas CD4+ T cells either help or suppress the generation of CD8+ cytotoxic T cells. However, in several experimental models as well as in cancer patients, it has been shown that CD4+ T cells can also mediate antitumor immunity either directly by killing tumor cells or indirectly by activating innate immune cells or by reducing tumor angiogenesis. In this review, we discuss the growing evidence of this underappreciated role of CD4+ T cells as mediators of antitumor immunity.
Topics & Concepts
Cytotoxic T cellImmune systemAcquired immune systemImmunityCD8ImmunologyEffectorInnate immune systemBiologyInterleukin 21AngiogenesisCancer researchCell biologyIn vitroBiochemistryCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune Responses